#parkinson039sdisease — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #parkinson039sdisease, aggregated by home.social.
-
A health ministry panel has approved healthcare coverage for Sumitomo Pharma's Parkinson's disease treatment Amchepry, making it the world's first commercialized medical product derived from iPS cells. https://www.japantimes.co.jp/news/2026/05/13/japan/science-health/ips-parkinsons-disease/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #mhlw #drugs #medicine #parkinson039sdisease #sumitomopharma #ips
-
A health ministry panel has approved healthcare coverage for Sumitomo Pharma's Parkinson's disease treatment Amchepry, making it the world's first commercialized medical product derived from iPS cells. https://www.japantimes.co.jp/news/2026/05/13/japan/science-health/ips-parkinsons-disease/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #mhlw #drugs #medicine #parkinson039sdisease #sumitomopharma #ips
-
A health ministry panel has approved healthcare coverage for Sumitomo Pharma's Parkinson's disease treatment Amchepry, making it the world's first commercialized medical product derived from iPS cells. https://www.japantimes.co.jp/news/2026/05/13/japan/science-health/ips-parkinsons-disease/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #mhlw #drugs #medicine #parkinson039sdisease #sumitomopharma #ips
-
A health ministry panel has approved healthcare coverage for Sumitomo Pharma's Parkinson's disease treatment Amchepry, making it the world's first commercialized medical product derived from iPS cells. https://www.japantimes.co.jp/news/2026/05/13/japan/science-health/ips-parkinsons-disease/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #mhlw #drugs #medicine #parkinson039sdisease #sumitomopharma #ips